This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
This time, plaintiff pleaded “1) violation of [defendant’s] premarket approval; 2) breach of implied warranty; and 3) lack of informedconsent (failure to warn).” Id. She also tried to sue three new defendants – a doctor, a medical society and the FDA itself. Mentor Worldwide LLC , 2014 WL 6390307 (D.S.C. 341 (2001).
Further, “both doctors testified that they still prescribe [the drug] for patients with conditions similar to plaintiff’s condition.” Abbott Laboratories , 2014 WL 4197494, at *7 (C.D. 8, 2019) (no causation where prescriber “testified that none of the additional risk information. . . Schering Corp. , 2d 1140, 1148 (N.J.
The law presumes that licensed doctors know what they are doing. 1978), where a hypertensive patient was injured after being injected with the defendant’s drug – despite warnings that “expressly directed the doctor administering the drug to refrain from giving it to a patient with hypertension.” 2014 WL 3798338 at *17 (N.J.
But what about cases where the plaintiff says, sure a stronger warning would not have influenced my doctor, but what about me? If my doctor had informed me, I would not have consented to the treatment. 2014) (applying California law)). The Ninth Circuit recently confronted a version of this scenario in Himes v.
We organize all of the trending information in your field so you don't have to. Join 26,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content